Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 6;15(8):1033.
doi: 10.3390/genes15081033.

A Genotype/Phenotype Study of KDM5B-Associated Disorders Suggests a Pathogenic Effect of Dominantly Inherited Missense Variants

Affiliations

A Genotype/Phenotype Study of KDM5B-Associated Disorders Suggests a Pathogenic Effect of Dominantly Inherited Missense Variants

Maria Carla Borroto et al. Genes (Basel). .

Abstract

Bi-allelic disruptive variants (nonsense, frameshift, and splicing variants) in KDM5B have been identified as causative for autosomal recessive intellectual developmental disorder type 65. In contrast, dominant variants, usually disruptive as well, have been more difficult to implicate in a specific phenotype, since some of them have been found in unaffected controls or relatives. Here, we describe individuals with likely pathogenic variants in KDM5B, including eight individuals with dominant missense variants. This study is a retrospective case series of 21 individuals with variants in KDM5B. We performed deep phenotyping and collected the clinical information and molecular data of these individuals' family members. We compared the phenotypes according to variant type and to those previously described in the literature. The most common features were developmental delay, impaired intellectual development, behavioral problems, autistic behaviors, sleep disorders, facial dysmorphism, and overgrowth. DD, ASD behaviors, and sleep disorders were more common in individuals with dominant disruptive KDM5B variants, while individuals with dominant missense variants presented more frequently with renal and skin anomalies. This study extends our understanding of the KDM5B-related neurodevelopmental disorder and suggests the pathogenicity of certain dominant KDM5B missense variants.

Keywords: KDM5; epigenetics; genetic syndromes; histone demethylation; intellectual disabilities; neurodevelopmental disorders; polygenetic interactions.

PubMed Disclaimer

Conflict of interest statement

Hans T. Bjornsson is a consultant for Mahzi Therapeutics. Paul Kruszka is an employee of GeneDx. The remaining authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Dominant and bi-allelic KDM5B variants from this cohort and the literature represented within the KDM5B protein. The active regions are named and highlighted in different colors according to the legend. Variant types are also indicated, and if the same one was shared by multiple individuals, it is shown as a circle with the total number. Illustration is adapted from https://proteinpaint.stjude.org/.
Figure 2
Figure 2
Photographs of individuals with KDM5B variants. (A) Individual No. 5 (p.Ala804Val) at the age of 10 years old. Note the macrotia, straight eyebrows, telecanthus, the full nasal tip, and the broad mouth. (B) Individual No. 19 (Whole gene deletion) at the age of 18 years old. Note the brachycephaly, elongated face, high forehead, temporally sparse hair, broad eyebrows, bilaterally temporal narrowing, downslanted palpebral fissures, short philtrum, facial asymmetry (left side is slightly shorter), increased cervical length and width, and large hands with long, tapered fingers. (C) Individual No. 21 (p.Glu2Ter and p.Trp387Ter) at the age of 4 years old. Note the broad forehead, the midface retraction, the full nasal tip, and the micrognathia.

Similar articles

Cited by

  • GREGoR: Accelerating Genomics for Rare Diseases.
    Dawood M, Heavner B, Wheeler MM, Ungar RA, LoTempio J, Wiel L, Berger S, Bernstein JA, Chong JX, Délot EC, Eichler EE, Gibbs RA, Lupski JR, Shojaie A, Talkowski ME, Wagner AH, Wei CL, Wellington C, Wheeler MT; GREGoR Partner Members; Carvalho CMB, Gifford CA, May S, Miller DE, Rehm HL, Sedlazeck FJ, Vilain E, O'Donnell-Luria A, Posey JE, Chadwick LH, Bamshad MJ, Montgomery SB; Genomics Research to Elucidate the Genetics of Rare Diseases (GREGoR) Consortium. Dawood M, et al. ArXiv [Preprint]. 2024 Dec 18:arXiv:2412.14338v1. ArXiv. 2024. PMID: 39764392 Free PMC article. Preprint.
  • Expanding the molecular landscape of childhood apraxia of speech: evidence from a single-center experience.
    Formicola D, Podda I, Dirupo E, Andreucci E, Giglio S, Cipriani P, Bombonato C, Santorelli FM, Chilosi A. Formicola D, et al. Front Neurosci. 2024 Sep 24;18:1396240. doi: 10.3389/fnins.2024.1396240. eCollection 2024. Front Neurosci. 2024. PMID: 39381681 Free PMC article.

References

    1. Travers A., Muskhelishvili G. DNA structure and function. FEBS J. 2015;282:2279–2295. doi: 10.1111/febs.13307. - DOI - PubMed
    1. Bowman G.D., Poirier M.G. Post-translational modifications of histones that influence nucleosome dynamics. Chem. Rev. 2015;115:2274–2295. doi: 10.1021/cr500350x. - DOI - PMC - PubMed
    1. Hughes T.R., Lambert S.A. Transcription factors read epigenetics. Science. 2017;356:489–490. doi: 10.1126/science.aan2927. - DOI - PubMed
    1. Dan J., Chen T. Chapter 3—Writers, erasers, and readers of DNA and histone methylation marks. In: Gray S.G., editor. Epigenetic Cancer Therapy. 2nd ed. Academic Press; Boston, MA, USA: 2023. pp. 39–63.
    1. Moore L.D., Le T., Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38:23–38. doi: 10.1038/npp.2012.112. - DOI - PMC - PubMed

Substances

LinkOut - more resources